Gene · 391051
UOX: urate oxidase (pseudogene)
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. UOX: urate oxidase (pseudogene). Genes, record 391051. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/391051
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants784
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | UOX papers | Newest fiscal year |
|---|---|---|---|
| R01HL086694 | From GWAS loci to blood pressure genes, variants & mechanisms - Renewal | 8 | 2025 |
| T32HL007024 | Cardiovascular Epidemiology Institutional Training | 8 | 2025 |
| R01AR065944 | NOVEL METABOLITE AND MICROBIOTA PATHWAYS FOR HYPERURICEMIA AND GOUT | 7 | 2025 |
| P30DK048520 | Colorado Nutrition Obesity Research Center | 6 | 2025 |
| R01AT011396 | Microbiota-based probiotics to treat inborn errors in metabolism | 4 | 2025 |
| R35GM142873 | Physiology of bacterial metabolism in the human gut microbiome | 4 | 2025 |
| T32AR007258 | Research Training in Rheumatology at Massachusetts General Hospital | 4 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 3 | 2025 |
| T32GM008315 | Mechanisms of Trauma-Induced Coagulopathy | 3 | 2025 |
| T32HL069768 | Pre-doctoral Training Program in Integrative Vascular Biology | 3 | 2025 |
1 to 10 of 784Source NIH's project files
See all 784 nih grantsPapers2,454
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PFOS increases cellular uric acid content and the abundance of URAT1 and GLUT9 in HK-2 cells. | Ecotoxicol Environ Saf | 2026 | 42801899 | PubTator, text mining | PubMed |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of HZBio1 in Chinese Healthy Subjects: A Randomized Phase 1a Study. | Adv Ther | 2026 | 42782449 | PubTator, text mining | PubMed |
| Integrated DoE strategy for the development of low-release hydrogels. | Chem Commun (Camb) | 2026 | 42733961 | PubTator, text mining | PubMed |
| Purine-Metabolism Reprogramming Associated with Failed-Repair Proximal Tubule States in the AKI-to-CKD Transition. | Metabolites | 2026 | 42646274 | PubTator, text mining | PubMed |
| The Development of Silver Nanoparticles-Based Colorimetric Uric Acid Detection: An Extension Study of Silver Nanoparticles Extraction from Water Hyacinth (Eichhornia crassipes). | Biosensors (Basel) | 2026 | 42645027 | PubTator, text mining | PubMed |
| Programmable cross-activity of catalase via functional state engineering in a uricase-catalase cascade nanogel. | Mater Horiz | 2026 | 42617048 | PubTator, text mining | PubMed |
| Pseudo-hypouricemia in four patients with lymphoma and one patient with breast cancer: Interference analysis and elimination. | Ann Clin Biochem | 2026 | 42613774 | PubTator, text mining | PubMed |
| Association of Peripheral TNF-α and IFN-γ Expression With Serum Uric Acid Levels and Clinical Disease Severity in Patients With Parkinson's Disease: A Cross-Sectional Study. | Cureus | 2026 | 42534208 | PubTator, text mining | PubMed |
| IgM-C4d Complex Causes the Inaccurate Measurement of Serum Uric Acid Levels via the Uricase Method. | Curr Issues Mol Biol | 2026 | 42510898 | PubTator, text mining | PubMed |
| Visual detection of uric acid and antibacterial applications in gout wound healing based on His@Fe-SHMP nanozyme. | Biosens Bioelectron | 2026 | 42413384 | PubTator, text mining | PubMed |
1 to 10 of 2,454
See all 2,454 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/391051
GET https://conductscience.org/api/genes/v1/391051/grants?page=2